UvA Ventures Holding

Anywyse is an audio learning platform that aims to facilitate skill acquisition through convenient listening. It offers users the ability to learn new topics while engaging in daily activities such as driving, exercising, or doing household chores. The platform provides small, easily digestible audio fragments on a variety of subjects, allowing learners to access information quickly and effectively. By delivering content in bite-sized pieces, Anywyse enables students to enhance their knowledge and prepare for exams, all while maximizing their time.

Kepler Vision Technologies specializes in developing AI-driven solutions for elder care centers, addressing the dual challenges of staff shortages and increasing demand for care. Their flagship product, the "Kepler Night Nurse" application, utilizes deep learning and computer vision to monitor clients during nighttime hours. This technology significantly reduces false alarms and minimizes the reporting workload for caregivers, allowing them to concentrate more on providing high-quality care. By analyzing live video streams, the software can detect when clients require assistance and promptly notify the on-duty nurse, thereby enhancing the overall efficiency of healthcare delivery. Founded as a spin-off from the University of Amsterdam, Kepler Vision Technologies aims to improve the operational dynamics of elder care facilities, ultimately benefiting both caregivers and clients.

ACE Incubator is a university startup incubator that actively supports researchers, scientists, students and entrepreneurs with tech-driven ideas looking to transform their concepts into a feasible business. ACE is equally owned by 4 acamedic institutions in Amsterdam: UvA, VU, HvA and Amsterdam UMC. Today the incubator is home to young entrepreneurs who develop world changing concepts in industries like Deep-tech, Medical & Health Technology, Chemical & Advanced Materials and Sustainable Technology. Offering tailored programs, startup facilities, entrepreneurial network and mentorship from the best startup experts, ACE supports ambitious science and high-tech entrepreneurs across every stage of starting a business.

Macrobian Biotech focuses on developing innovative healthcare treatments for disorders that impact the midbrain dopamine system. The company engages in both fundamental and clinical research within the neuroscience field, utilizing advanced technologies in genetics and transcriptomics. Through extensive gene function research, Macrobian Biotech aims to create clinical trial-ready compounds that address neurological and neuropsychiatric diseases, providing healthcare practitioners with effective treatment options.

Confocal.nl B.V., based in Amsterdam, the Netherlands, specializes in the development of advanced confocal microscopes aimed at enhancing microscopy imaging. The company focuses on creating user-friendly, plug-and-play systems, including its innovative Re-scan Confocal Microscope (RCM), which boasts improved resolution and sensitivity compared to conventional models. Confocal.nl's microscopes are designed to be highly customizable, catering to the specific needs of laboratories while remaining affordable. Their modular design allows for integration with existing wide-field fluorescence microscopes, making it accessible even for researchers with limited microscopy experience. The company emphasizes an open-architecture approach, ensuring that its systems are platform- and software-independent, thereby fostering innovation within the microscopy industry.

Haermonics is a clinical stage medtech company focused on developing innovative therapies aimed at preventing complications associated with post-operative cardiac surgery. The company prioritizes addressing significant medical challenges through a disciplined and creative approach, ensuring thorough testing of its solutions. By striving to enhance the safety and efficacy of open-heart surgeries, Haermonics seeks to improve patient outcomes in this critical area of healthcare.

Sightcorp is an AI spin-off from the University of Amsterdam. We develop patented proprietary AI Software solutions. Through computer vision and deep learning, we can analyze faces in images, videos, and in real-life environments. We transform computer vision and deep learning research into commercial solutions that give our customers accurate, real and actionable insights into their audiences.

SigmaScreening B.V. is a medical device company based in Amsterdam, Netherlands, specializing in breast cancer screening technologies. Founded in 2010 as a spin-off from the Academic Medical Center Amsterdam, the company is dedicated to enhancing digital mammography, which is widely regarded as the gold standard in breast cancer detection. SigmaScreening develops innovative products, including the Sensitive Sigma Paddle, which measures the mechanical properties of breast tissue during compression. This technology optimizes the compression process for individual patients, reducing discomfort while improving the effectiveness of mammography. By focusing on these advancements, SigmaScreening aims to facilitate earlier cancer detection, ultimately contributing to better patient outcomes and saving lives.

InCatT B.V., which stands for Innovative Catalyst Technologies, is a spin-off company of the homogeneous catalysis group of Prof. Dr. Joost Reek at the University of Amsterdam who has introduced new supramolecular strategies in transition metal catalysis.

Photanol is engaged in developing innovative technology that transforms CO2 and sunlight into valuable organic compounds using engineered cyanobacteria. This process enables the production of various products, including biofuels, food ingredients, and chemical bio-blocks. The company employs a team of researchers specializing in molecular biology, biochemistry, and process engineering, focusing on creating efficient methods to capture sunlight and convert it into biochemical compounds. By leveraging its proprietary technology, Photanol aims to provide affordable and sustainable solutions for clients in different markets, addressing both environmental challenges and the demand for renewable resources.

Arthrogen is a biopharmaceutical company based in Amsterdam that focuses on developing local gene therapy for inflammatory diseases. The company utilizes viral-mediated gene transfer, specifically adeno-associated virus (AAV)-based therapeutics, to address various health conditions. Its primary emphasis is on treating rheumatic diseases, aiming to provide effective solutions for managing these inflammatory disorders. By specializing in the creation of viral gene therapy vectors, Arthrogen seeks to advance treatment options for health professionals dealing with inflammatory diseases.